ScoreWhy is Kiniksa Pharmaceuticals International Plc ?
1
With a growth in Net Profit of 59.11%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 165.86 MM
- ROCE(HY) Highest at 13.74%
- DEBT-EQUITY RATIO (HY) Lowest at -75.79 %
2
With ROE of 10.40%, it has a very attractive valuation with a 6.17 Price to Book Value
- Over the past year, while the stock has generated a return of 107.14%, its profits have risen by 236.6%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
- Along with generating 107.14% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Kiniksa Pharmaceuticals International Plc should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
268.40%
EBIT Growth (5y)
20.02%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
59
Industry P/E
Price to Book Value
6.17
EV to EBIT
40.02
EV to EBITDA
39.23
EV to Capital Employed
19.74
EV to Sales
4.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
49.34%
ROE (Latest)
10.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend37What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 165.86 MM
ROCE(HY)
Highest at 13.74%
DEBT-EQUITY RATIO
(HY)
Lowest at -75.79 %
NET SALES(Q)
Highest at USD 214.27 MM
RAW MATERIAL COST(Y)
Fallen by 0.52% (YoY
CASH AND EQV(HY)
Highest at USD 882.17 MM
OPERATING PROFIT(Q)
Highest at USD 29.73 MM
OPERATING PROFIT MARGIN(Q)
Highest at 13.88 %
PRE-TAX PROFIT(Q)
Highest at USD 32.68 MM
NET PROFIT(Q)
Highest at USD 22.59 MM
EPS(Q)
Highest at USD 0.27
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Kiniksa Pharmaceuticals International Plc
Operating Cash Flow
Highest at USD 165.86 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 214.27 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Debt-Equity Ratio
Lowest at -75.79 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales
At USD 214.27 MM has Grown at 26.49%
over average net sales of the previous four periods of USD 169.39 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 29.73 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 13.88 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 32.68 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD 32.68 MM has Grown at 47.1%
over average net sales of the previous four periods of USD 22.22 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 22.59 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD 22.59 MM has Grown at 53.15%
over average net sales of the previous four periods of USD 14.75 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.27
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 882.17 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by 0.52% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
